Today’s Best Market Rumors (7/16/2012) GlaxoSmithKline Buys Human Genome Sciences

Print Email

Updated throughout the day on the 24/7 Wall St. Wire:

GlaxoSmithKline (NYSE: GSK) will buy Human Genome Sciences (NASDAQ: HGSI) for $2.8 billion. (Reuters)

The Justic Department and HSBC (NYSE: HBC) are close to a settlement on money laundering for drug cartel charges. (WSJ)

Douglas A. McIntyre

RSS Facebook Twitter